Literature DB >> 19225544

Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis.

Kathryn E McDougal1, M Daniele Fallin, David R Moller, Zhimin Song, David J Cutler, Lori L Steiner, Garry R Cutting.   

Abstract

Sarcoidosis is a multi-system inflammatory disease with organ involvement that varies by race and sex. Family studies indicate that genes play a role in the etiology and extent of organ involvement in sarcoidosis. In this study, we evaluated whether 25 variants distributed in 19 genes with a known role in inflammation were associated with erythema nodosum status in 659 sarcoidosis patients and 658 controls from A Case-Control Etiologic Study of Sarcoidosis (ACCESS). We found no association with affectation status; however, a variant in the promoter of tumor necrosis factor (TNF) at position -308 was found to be associated with erythema nodosum in Caucasian sarcoidosis patients (study-wide P=0.027). When separated by sex, a variant in intron 1 of lymphotoxin-alpha (LTA), a gene adjacent to TNF, was associated with erythema nodosum in female Caucasian sarcoidosis patients (study-wide P=0.027). These DNA variants frequently occur together in Caucasians, and each variant has individually been associated with erythema nodosum in sarcoidosis patients. These results confirm that variation in the LTA/TNF gene cluster modifies a major skin manifestation of sarcoidosis and may explain the higher rate of erythema nodosum in females with sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225544      PMCID: PMC2877485          DOI: 10.1038/jid.2008.456

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  41 in total

Review 1.  Epidemiology of sarcoidosis.

Authors:  D G James
Journal:  Sarcoidosis       Date:  1992-09

Review 2.  Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis.

Authors:  M A Judson; R P Baughman; A S Teirstein; M L Terrin; H Yeager
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  1999-03       Impact factor: 0.670

3.  Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis.

Authors:  U Seitzer; C Swider; F Stüber; K Suchnicki; A Lange; E Richter; P Zabel; J Müller-Quernheim; H D Flad; J Gerdes
Journal:  Cytokine       Date:  1997-10       Impact factor: 3.861

4.  The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.

Authors:  K M Kroeger; K S Carville; L J Abraham
Journal:  Mol Immunol       Date:  1997-04       Impact factor: 4.407

5.  Course and prognosis of sarcoidosis around the world.

Authors:  L E Siltzbach; D G James; E Neville; J Turiaf; J P Battesti; O P Sharma; Y Hosoda; R Mikami; M Odaka
Journal:  Am J Med       Date:  1974-12       Impact factor: 4.965

Review 6.  The treatment of lepra reaction in lepromatous leprosy. Fifteen years' experience with thalidomide.

Authors:  J Sheskin
Journal:  Int J Dermatol       Date:  1980 Jul-Aug       Impact factor: 2.736

7.  Erythema nodosum. A review.

Authors:  R M Soderstrom; E A Krull
Journal:  Cutis       Date:  1978-06

8.  Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon.

Authors:  B B Aggarwal; T E Eessalu; P E Hass
Journal:  Nature       Date:  1985 Dec 19-1986 Jan 1       Impact factor: 49.962

Review 9.  Human tumour necrosis factors-alpha and -beta: differences in their structure, expression and biological properties.

Authors:  A G Porter
Journal:  FEMS Microbiol Immunol       Date:  1990-11

10.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

View more
  7 in total

Review 1.  Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.

Authors:  Johan Grunewald; Paolo Spagnolo; Jan Wahlström; Anders Eklund
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

2.  The Immunogenetics of Granulomatous Diseases.

Authors:  Gizem Filazi Kök; Ümit Türsen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Associations between TNF-α -308 A/G and lymphotoxin-α +252 A/G polymorphisms and susceptibility to sarcoidosis: a meta-analysis.

Authors:  Gwan Gyu Song; Jae-Hoon Kim; Young Ho Lee
Journal:  Mol Biol Rep       Date:  2013-11-07       Impact factor: 2.316

Review 4.  Dendritic cells in the pathogenesis of sarcoidosis.

Authors:  Lisa C Zaba; Gideon P Smith; Miguel Sanchez; Stephen D Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-16       Impact factor: 6.914

5.  A genome-wide admixture scan for ancestry-linked genes predisposing to sarcoidosis in African-Americans.

Authors:  B A Rybicki; A M Levin; P McKeigue; I Datta; C Gray-McGuire; M Colombo; D Reich; R R Burke; M C Iannuzzi
Journal:  Genes Immun       Date:  2010-12-23       Impact factor: 2.676

Review 6.  Erythema nodosum - review of the literature.

Authors:  Małgorzata Chowaniec; Aleksandra Starba; Piotr Wiland
Journal:  Reumatologia       Date:  2016-06-03

Review 7.  Offense and Defense in Granulomatous Inflammation Disease.

Authors:  Xinwen Wang; Yuan Liu
Journal:  Front Cell Infect Microbiol       Date:  2022-06-29       Impact factor: 6.073

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.